Updated August 2026. Shanghai is home to one of China's highest concentrations of medical excellence — and at the centre of it is Fudan University Shanghai Cancer Center (FUSCC). Consistently ranked among the top three cancer hospitals in China by Fudan University's own annual hospital rankings, FUSCC is a comprehensive oncology centre that treats a very high volume of cancer patients across every major disease site and stage.
This page gives you what we know about FUSCC — its position in the Chinese healthcare system, the types of cancer care it delivers, how international patients access it through Verified China Care, and what you can expect in terms of cost and experience. All information is based on publicly available sources and our coordination experience.
1. About FUSCC
Fudan University Shanghai Cancer Center is affiliated with Fudan University's School of Medicine, one of China's most prestigious medical schools. Its history traces back to the mid-20th century, and over decades it has grown into a national reference centre for oncology.
Key facts we can confirm from public sources:
- It is consistently ranked among the top three cancer hospitals in China in independent national hospital evaluations published by Fudan University.
- It operates multiple campuses across Shanghai, serving tens of thousands of cancer patients each year across all major disease categories.
- Its departments cover the full spectrum of oncology: surgical oncology, medical oncology, radiation oncology, hematology-oncology, breast cancer, digestive oncology, thoracic oncology, head-and-neck oncology, gynecologic oncology, pediatric oncology, palliative care, and more.
- The hospital conducts extensive clinical research and participates in multi-center trials alongside international research networks.
2. What FUSCC offers
FUSCC's service scope covers virtually every modality used in modern oncology:
- Surgical oncology: Resection of solid tumours across all organs using conventional and minimally invasive techniques, including robotic-assisted procedures at designated campuses.
- Medical oncology: Systemic chemotherapy, targeted therapy, and immunotherapy (including PD-1 and PD-L1 checkpoint inhibitors approved by China's NMPA).
- Radiation oncology: IMRT, SBRT, and other advanced conformal techniques. Connections to proton therapy programs through partner facilities give FUSCC patients access to the modality when clinically indicated.
- CAR-T and immune cell therapy: FUSCC participates in domestic CAR-T clinical programs and has active translational research platforms. Patients interested in CAR-T outside approved trial protocols can be directed to the Boao Lecheng zone where commercial products are available under a different regulatory pathway.
- Multidisciplinary tumor boards: Every complex case is reviewed by a team of surgeons, medical oncologists, radiation oncologists, pathologists, and radiologists who jointly determine the optimal approach. This is standard practice at FUSCC for staged or advanced disease.
- Palliative and supportive care: Dedicated pain management and symptom-control programs integrated into the treatment pathway.
3. How to access FUSCC through Verified China Care
The process for international patients mirrors how we coordinate with all our partner hospitals:
- Record submission. You send pathology reports, imaging (DICOM files if available), and current treatment summary. A physician reviewer at FUSCC confirms eligibility within 24–48 hours.
- Treatment plan. The reviewing surgeon or medical oncologist outlines a recommended approach — including which modality (surgery, systemic therapy, radiation, combination), approximate timeline, and whether additional diagnostics are needed before starting.
- All-in quote. Itemized: hospital stay, physician fees, medications/infusions, room, translation, airport pickup, coordination fee. Everything in one number.
- Treatment agreement + escrow. You sign directly with the hospital. Payment goes to escrow, released only as milestones are met.
- Travel and treatment. Visa support, flight coordination, hotel booking near the hospital. An English-speaking coordinator is on the ground.
4. Cost context for FUSCC
FUSCC is a public teaching hospital operating under government-guided pricing. Here's how that translates in practice. These figures are consistent with those published on our main cost guide and come from the same hospital price list sources collected 2025–2026.
| Oncology Service | Typical US price | FUSCC / China all-in | Savings |
|---|
| CAR-T cell therapy | $500,000+ | $89,000–170,000 | ~70% |
| Immunotherapy (PD-1/PD-L1) | $150,000–250,000/yr | $25,000–45,000/yr | ~80% |
| Proton therapy | $100,000–180,000 | $40,000–60,000 | ~65% |
| Robotic surgery (Da Vinci) | $60,000–120,000 | $20,000–40,000 | ~65% |
| Radiation (IMRT/SBRT) | $30,000–80,000 | $8,000–18,000 | ~75% |
| Diagnostic workup | $8,000–25,000 | $1,500–4,000 | ~80% |
For full methodology and source citations, see our Cancer Treatment in China cost guide. Your individual quote may differ — request a free case review.
5. Why consider FUSCC specifically?
China has several excellent cancer centers — PUMCH Beijing for complex undiagnosed cases, Guangzhou Fuda Cancer Hospital for dedicated cancer-only care, Ruijin Shanghai for comprehensive tertiary care. FUSCC occupies a distinctive position because:
- Cancer-specialisation: Unlike general hospitals where oncology is one department among many, FUSCC's entire institutional mission is oncology. Every department, every resource line is laser-focused on cancer.
- Volume: High case volume across all sub-sites produces deep sub-specialty expertise — whether you have oesophageal cancer, hepatocellular carcinoma, lung adenocarcinoma, or breast cancer, there will be a team whose sole focus is your disease.
- Shanghai accessibility: As China's largest city, Shanghai has exceptional air connectivity (Pudong and Hongqiao airports serve dozens of direct international routes). Many international patients combine treatment with brief recovery stays in a city that offers familiar conveniences alongside authentic cultural experiences.
- Research integration: Being part of Fudan University's academic ecosystem means FUSCC physicians stay current with global literature and participate in clinical trials — giving patients access to the latest evidence-based approaches.
6. Escrow protection — your payment safety net
Our escrow structure ensures that every dollar you commit is protected. Details are identical to our standard model described across this site — see our escrow explainer or the cancer guide section on escrow.
In short: you pay an independent third-party escrow agent, funds are released to the hospital only after documented treatment milestones, and if the hospital fails to deliver agreed-upon care, the money stays frozen until resolution.
8. FAQ — FUSCC
How is Fudan University Shanghai Cancer Center ranked among Chinese cancer hospitals?
FUDAN University Shanghai Cancer Center consistently ranks among the top three cancer hospitals in China according to independent hospital ranking assessments published annually by Fudan University itself. It is widely regarded as one of China's premier oncology centres.
What cancer treatments are available at FUSCC?
FUSCC provides comprehensive oncology care including surgical oncology (solid tumour resection across all major sites), medical oncology (chemotherapy, immunotherapy including PD-1/PD-L1 combinations, targeted therapies), radiation therapy (IMRT, SBRT), and CAR-T cell therapy programs. The hospital also has connections to the Boao Lecheng zone for FDA-approved advanced immunotherapies not yet registered on the mainland.
Does FUSCC have an international department for foreign patients?
Yes. The hospital operates dedicated international patient services that provide English-language coordination, expedited appointments, and culturally-adapted support. We work with this department to coordinate record review, physician consultation, treatment planning, and escrow-protected payment arrangements.
How do costs at FUSCC compare to Western prices?
FUSCC is a public teaching hospital, so its pricing follows government-guided rates. Typical savings compared to US or European self-pay prices range from 70–80%. For example, CAR-T cell therapy at approximately $89,000–$170,000 versus $500,000+ in the US. Immunotherapy courses around $25,000–$45,000 per year versus $150,000–$250,000 in the US. Our cost guide has the full breakdown.
Can I get a second opinion before committing to treatment at FUSCC?
Absolutely. Our standard process includes sending your records to a FUSCC physician reviewer for an initial assessment — essentially a structured remote second opinion. You receive a written treatment recommendation before you book travel or fund any payments. We also encourage patients to seek independent second opinions anywhere they wish.
Important: outcomes vary by patient, disease stage, and treatment. We never promise cures. The escrow protects your money, not the medical outcome — always get a second opinion and a clear written treatment plan before committing.
